Loading the map…
Research and experimental development on biotechnology · London
Promatix Biosciences
Promatix Biosciences Ltd
Private limited company registered in London, classed under “Research and experimental development on biotechnology”.
Headline figures
FY to Dec 2025 · Company only
Turnover
For subscribers
Profit after tax
—
Not filed: small-company exemption
Net assets
For subscribers
Cash
For subscribers
Employees
For subscribers
What the numbers say
2 findings from the figures, in plain English
Written by rules from the figures on this page. Not a forecast or a credit opinion.
History
| £ | 2022* | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Profit after tax | — | |||
| Turnover | ||||
| Net assets | ||||
| Cash | ||||
| Employees |
Every figure for all 4 years
“—” means we did not find the figure in a source; it is never filled with an estimate. * Restated: the next year's accounts printed different figures for this year, and those later figures are shown.
Balance sheet and ratios
From the filed balance sheets · £
| Balance sheet | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Fixed assets | ||||
| Current assets | ||||
| Creditors due within a year | ||||
| Net current assets | ||||
| Creditors due after a year | ||||
| Net assets | ||||
| Ratios | ||||
| Current ratioCurrent assets for every £1 owed within a year | ||||
| Creditors to assetsEverything owed to creditors as a share of fixed plus current assets | ||||
6 balance-sheet lines and 2 ratios, every year
A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.
Timeline
Checked 2026-10-27
- AccountsMicro company accounts made up to 31 December 2025
- ChargesRegistration of charge 135854000002, created on 16 March 2026
- DirectorsDirector's details changed for Mr Alek Safarian on 6 April 2025
- OwnershipChange of details for Mr Alek Safarian as a person with significant control on 6 April 2025
- AccountsMicro company accounts made up to 31 December 2024
- DirectorsAppointment of Dr Graeme Richard Martin as a director on 14 October 2024
- FilingMemorandum and Articles of Association
- SharesStatement of capital following an allotment of shares on 21 May 2024 · GBP 50 (and 2 more like it since 5 May 2022)
- ChargesRegistration of charge 135854000001, created on 9 May 2024
- AccountsMicro company accounts made up to 31 December 2023
- AccountsCurrent accounting period extended from 31 August 2023 to 31 December 2023
- DirectorsAppointment of Dr Robert Henry Balfour as a director on 23 January 2023
2 earlier
- AccountsMicro company accounts made up to 31 August 2022
- IncorporationIncorporation
- Accounts
From the Companies House filing history. Routine confirmation statements are left out, and a run of the same filing is shown once.
Questions people ask
›What does Promatix Biosciences do?
Private limited company registered in London, classed under “Research and experimental development on biotechnology”.
›How much turnover does Promatix Biosciences make?
Answered in the full report
›Is Promatix Biosciences profitable?
Promatix Biosciences's profit isn't public: small companies may file without a profit and loss account.
›How many people work at Promatix Biosciences?
Answered in the full report
›Who runs and owns Promatix Biosciences?
Its directors are Robert Henry Balfour, Graeme Richard Martin, Alek Safarian. Its owners are shown to subscribers.
›Where is Promatix Biosciences based?
Its registered office is 78 Pall Mall, London, SW1Y 5ES, in London.
›When was Promatix Biosciences founded?
Promatix Biosciences Ltd was incorporated on 25 August 2021.
›Is Promatix Biosciences still trading?
The register lists Promatix Biosciences Ltd as active.